哌嗪-1-乙酸甲酯双盐酸盐结构式
|
常用名 | 哌嗪-1-乙酸甲酯双盐酸盐 | 英文名 | 1-Piperazineaceticacid,methylester(9CI) |
---|---|---|---|---|
CAS号 | 82516-17-4 | 分子量 | 402.481 | |
密度 | 1.2±0.1 g/cm3 | 沸点 | 528.8±50.0 °C at 760 mmHg | |
分子式 | C23H30O6 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 228.0±30.2 °C |
中文名 | 哌嗪-1-乙酸甲酯双盐酸盐 |
---|---|
英文名 | piperazin-1-ylmethyl acetate |
英文别名 | 更多 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 528.8±50.0 °C at 760 mmHg |
分子式 | C23H30O6 |
分子量 | 402.481 |
闪点 | 228.0±30.2 °C |
精确质量 | 402.204254 |
PSA | 41.57000 |
LogP | 4.00 |
蒸汽压 | 0.0±1.4 mmHg at 25°C |
折射率 | 1.543 |
海关编码 | 2933599090 |
---|
~% 哌嗪-1-乙酸甲酯双盐酸盐 82516-17-4 |
文献:WO2006/62240 A1, ; Page/Page column 575-576 ; |
~% 哌嗪-1-乙酸甲酯双盐酸盐 82516-17-4 |
文献:WO2007/7072 A1, ; Page/Page column 73-74 ; WO 2007/007072 A1 |
哌嗪-1-乙酸甲酯双盐酸盐上游产品 3 | |
---|---|
哌嗪-1-乙酸甲酯双盐酸盐下游产品 0 |
海关编码 | 2933599090 |
---|---|
中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
deacetylbowdensine |
methyl 2-piperazinoacetate |
1-Piperazineaceticacid,methyl ester |
1H-4,9a-Ethanocyclohepta[c]pyran-7-carboxylic acid, 3-[(1E,3E)-4-carboxy-1,3-pentadien-1-yl]-3,4,4a,5,6,9-hexahydro-4a-hydroxy-3-methyl-1-oxo-, (3R,4R,4aS,9aR)- |
2,4-Pentadienoic acid, 5-[(3R,4R,4aS,9aR)-3,4,4a,5,6,9-hexahydro-4a-hydroxy-3,7-dimethyl-1-oxo-1H-4,9a-ethanocyclohepta[c]pyran-3-yl]-2-methyl-, (2E,4E)- |
1-methyloxycarbonylmethylpiperazine |
(1R,7S,8R,9R)-9-[(1E,3E)-4-Carboxy-1,3-pentadien-1-yl]-7-hydroxy-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-ene-4-carboxylic acid |
2,4-Pentadienoic acid, 5-[(3R,4S,4aS,9aR)-4a-(acetyloxy)-3,4,4a,5,6,9-hexahydro-3,7-dimethyl-1-oxo-1H-4,9a-ethanocyclohepta[c]pyran-3-yl]-2-methyl-, methyl ester, (2E,4E)- |
Methyl (1R,7S,8S,9R)-7-acetoxy-9-[(1E,3E)-5-methoxy-4-methyl-5-oxo-1,3-pentadien-1-yl]-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-ene-4-carboxylate |
Methyl (2E,4E)-5-[(1R,7S,8S,9R)-7-acetoxy-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-en-9-yl]-2-methyl-2,4-pentadienoate |
1-Epidideacetylbowdensine |
1H-4,9a-Ethanocyclohepta[c]pyran-7-carboxylic acid, 4a-(acetyloxy)-3,4,4a,5,6,9-hexahydro-3-[(1E,3E)-5-methoxy-4-methyl-5-oxo-1,3-pentadien-1-yl]-3-methyl-1-oxo-, methyl ester, (3R,4S,4aS,9aR)- |
(2E,4E)-5-[(3R,4R,4aS,9aR)-4a-hydroxy-3,7-dimethyl-1-oxo-3,4,4a,5,6,9-hexahydro-4,9a-ethanocyclohepta[c]pyran-3(1H)-yl]-2-methylpenta-2,4-dienoic acid |
Methyl piperazinoacetate |
Di-O-deacetyl-1-epibowdensine |
Methyl1-piperazineacetate |
(2E,4E)-5-[(1R,7S,8R,9R)-7-Hydroxy-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.0]tridec-3-en-9-yl]-2-methyl-2,4-pentadienoic acid |
deacetylpseudolaric acid A |